These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 9086288)

  • 21. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetic assessment of the sites of first-pass metabolism of BMS-181101, an antidepressant agent, in rats.
    Vachharajani NN; Shyu WC; Shah VR; Barbhaiya RH
    J Pharm Pharmacol; 1998 Mar; 50(3):275-8. PubMed ID: 9600718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in pentobarbital pharmacokinetics in response to parenteral and enteral alimentation in the rat.
    Knodell RG; Spector MH; Brooks DA; Keller FX; Kyner WT
    Gastroenterology; 1980 Dec; 79(6):1211-6. PubMed ID: 6777235
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presystemic and systemic intestinal metabolism of fenoterol in the conscious rat.
    Koster AS; Hofman GA; Frankhuijzen-Sierevogel AC; Noordhoek J
    Drug Metab Dispos; 1985; 13(4):464-70. PubMed ID: 2863112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of pharmacokinetics, brain levels and protein binding of centpropazine in rats.
    Bhattaram VA; Paliwal JK; Gupta RC
    Biopharm Drug Dispos; 2004 Mar; 25(2):69-75. PubMed ID: 14872554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics of [14C]ciclesonide after oral and intravenous administration to healthy subjects.
    Nave R; Bethke TD; van Marle SP; Zech K
    Clin Pharmacokinet; 2004; 43(7):479-86. PubMed ID: 15139796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and first-pass elimination of metoprolol in rats: contribution of intestinal first-pass extraction to low bioavailability of metoprolol.
    Yoon IS; Choi MK; Kim JS; Shim CK; Chung SJ; Kim DD
    Xenobiotica; 2011 Mar; 41(3):243-51. PubMed ID: 21128757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-linear pharmacokinetics of piperine and its herb-drug interactions with docetaxel in Sprague-Dawley rats.
    Li C; Wang Q; Ren T; Zhang Y; Lam CWK; Chow MSS; Zuo Z
    J Pharm Biomed Anal; 2016 Sep; 128():286-293. PubMed ID: 27288758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regional pharmacokinetics of 5-bromo-2'-deoxyuridine and 5-fluorouracil in dogs: hepatic arterial versus portal venous infusions.
    Kuan HY; Smith DE; Ensmiger WD; Knol JA; DeRemer SJ; Yang Z; Stetson PL
    Cancer Res; 1996 Oct; 56(20):4724-7. PubMed ID: 8840990
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gender-related pharmacokinetics and absolute bioavailability of diosbulbin B in rats determined by ultra-performance liquid chromatography-tandem mass spectrometry.
    Yang B; Wang X; Liu W; Zhang Q; Chen K; Ma Y; Wang C; Wang Z
    J Ethnopharmacol; 2013 Oct; 149(3):810-5. PubMed ID: 23954278
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.
    Shim HJ; Kim YC; Park KJ; Kim DS; Kwon JW; Kim WB; Lee MG
    J Pharm Sci; 2003 Nov; 92(11):2185-95. PubMed ID: 14603504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Simultaneous evaluation of intestinal absorption and hepatic extraction of 5-fluorouracil using portal-systemic concentration difference by short-period double dosing in a single conscious rat.
    Sawai Y; Yamaoka K; Ito T; Nakagawa T
    Biol Pharm Bull; 1997 Dec; 20(12):1313-6. PubMed ID: 9448112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of temozolomide in association with fotemustine in malignant melanoma and malignant glioma patients: comparison of oral, intravenous, and hepatic intra-arterial administration.
    Marzolini C; Decosterd LA; Shen F; Gander M; Leyvraz S; Bauer J; Buclin T; Biollaz J; Lejeune F
    Cancer Chemother Pharmacol; 1998; 42(6):433-40. PubMed ID: 9788568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Bioavailability and mammary excretion of bisphenol a in Sprague-Dawley rats.
    Yoo SD; Shin BS; Lee BM; Lee KC; Han SY; Kim HS; Kwack SJ; Park KL
    J Toxicol Environ Health A; 2001 Nov; 64(5):417-26. PubMed ID: 11700006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and bioavailability of a newly synthesized dihydropyridine compound with multidrug resistance reversal activity.
    Zhou XF; Macdiarmid J; Coburn RA; Morris ME
    Biopharm Drug Dispos; 2005 Oct; 26(7):279-85. PubMed ID: 15991253
    [TBL] [Abstract][Full Text] [Related]  

  • 37. First-pass metabolism of omeprazole in rats.
    Watanabe K; Furuno K; Eto K; Oishi R; Gomita Y
    J Pharm Sci; 1994 Aug; 83(8):1131-4. PubMed ID: 7983597
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatic and gastrointestinal first-pass effects of vitexin-4″-O-glucoside in rats.
    Chen Y; Zhang W; Li D; Ai J; Meng Y; Ying X; Kang T
    J Pharm Pharmacol; 2013 Oct; 65(10):1500-7. PubMed ID: 24028617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of the primary determining factor(s) governing the oral absorption of edaravone in rats.
    Hyung S; Jeong YS; Yeo J; Song YK; Kim MS; Im YJ; Maeng HJ; Chung SJ
    Eur J Pharm Sci; 2018 Oct; 123():312-320. PubMed ID: 30056192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced oral bioavailability of docetaxel in rats combined with myricetin: In situ and in vivo evidences.
    Hao T; Ling Y; Wu M; Shen Y; Gao Y; Liang S; Gao Y; Qian S
    Eur J Pharm Sci; 2017 Apr; 101():71-79. PubMed ID: 28185989
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.